NDT Advance Access originally published online on October 30, 2007
Nephrology Dialysis Transplantation 2008 23(2):627-635; doi:10.1093/ndt/gfm603
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hepatocyte nuclear factor-1β gene deletions—a common cause of renal disease
1Institute of Biomedical and Clinical Science, Peninsula Medical School and 2Department of Molecular Genetics, Royal Devon and Exeter NHS Foundation Trust, Barrack Road, Exeter, UK
Corresponding to: Dr Coralie Bingham, Royal Devon and Exeter NHS Foundation Trust, Barrack Road, Exeter, EX2 5DW, UK. Email: c.bingham{at}exeter.ac.uk
 |
Abstract |
|---|
Background. Hepatocyte nuclear factor-1β (HNF-1β) is a critical transcription factor in pancreatic and renal development. Our previous report identified HNF-1β mutations in 23/160 patients with unexplained renal disease. The most common phenotype is renal cysts, which is frequently associated with early-onset diabetes in the renal cysts and diabetes (RCAD) syndrome. HNF-1β gene deletions have recently been shown to cause renal malformations and early-onset diabetes.
Methods. We developed a multiplex ligation-dependent probe amplification (MLPA) assay for HNF-1β gene dosage analysis and tested patients with unexplained renal disease in whom mutations had not been found by sequencing.
Results. Whole HNF-1β gene deletions were detected in 15/133 probands. Renal cysts were present in 13/15, including three with glomerulocystic kidney disease and one with cystic renal dysplasia. Renal function ranged from normal to transplantation aged 3 years. Ten probands had diabetes (nine having RCAD). In addition, four had abnormal liver function tests, two showed pancreatic atrophy and 3/10 female probands had uterine malformations. Whole HNF-1β gene deletions are a common cause of developmental renal disease, particularly renal cystic disease with or without diabetes.
Conclusions. The phenotype associated with deletions or coding region/splicing mutations is very similar suggesting that haploinsufficiency is the underlying mechanism. Patients with features suggestive of the HNF-1β clinical phenotype should be tested for mutations both by sequence and dosage analysis.
Keywords: HNF-1β; renal disease; diabetes; deletion mutation
Received for publication: 13. 4.07
Accepted in revised form: 7. 8.07
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Adalat, A. S. Woolf, K. A. Johnstone, A. Wirsing, L. W. Harries, D. A. Long, R. C. Hennekam, S. E. Ledermann, L. Rees, W. van't Hoff, et al. HNF1B Mutations Associate with Hypomagnesemia and Renal Magnesium Wasting J. Am. Soc. Nephrol., May 1, 2009; 20(5): 1123 - 1131. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Murray, K. Thomas, C. J. Mulgrew, S. Ellard, E. L. Edghill, and C. Bingham Whole gene deletion of the hepatocyte nuclear factor-1{beta} gene in a patient with the prune-belly syndrome Nephrol. Dial. Transplant., July 1, 2008; 23(7): 2412 - 2415. [Full Text] [PDF]
|
|